Okay, let's tackle this question step by step. The question is about a patient with amenorrhea who had pituitary ablation for a craniopharyngioma. The task is to determine which regimen would result in an ovulatory cycle. First, I need to recall the hormonal axis involved in menstruation.

The hypothalamic-pituitary-gonadal (HPG) axis is crucial here. The pituitary gland produces luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which are necessary for ovarian function. If the pituitary has been ablated, the patient would have low or absent LH and FSH, leading to hypoestrogenism and amenorrhea.

The correct treatment would be to replace these hormones to stimulate the ovaries. However, since the pituitary is non-functional, the patient might need exogenous gonadotropins. Alternatively, if the ovaries are intact, estrogen and progestin could be given to induce a cycle. But to get an ovulatory cycle, the regimen must include both LH and FSH to stimulate follicular development and ovulation.

Looking at the options, the correct answer would be a regimen that includes both FSH and LH, such as menotropins (a combination of FSH and LH). Other options might include estrogen-only, which would not induce ovulation, or progestin-only, which would only affect the endometrium without ovulation. A GnRH agonist might not be effective if the pituitary is ablated since it relies on the pituitary to release LH/FSH in response.

So, the key is that without functional pituitary, the patient can't produce LH/FSH, so exogenous gonadotropins are needed to stimulate the ovaries directly.

**Core Concept**
The hypothalamic-pituitary-gonadal (HPG) axis regulates ovarian function via gonadotropin secretion (LH and FSH). Pituitary ablation disrupts this axis, causing hypoestrogenism and amenorrhea. Restoring ovulation requires direct ovarian stimulation with exogenous gonadotropins.

**Why the Correct Answer is Right**
To induce ovulation in pituitary ablation, a regimen must bypass the pituitary and stimulate the ovaries directly. Menotropins (a combination of urinary FSH and LH) or recombinant FSH/LH are administered to promote follicular development and ovulation. Estrogen/progestin combinations or GnRH agonists cannot restore ovulation without functional pituitary release of LH/FSH.

**Why Each Wrong Option is Incorrect**
**Option A:** Estrogen-only therapy induces a pseudomenstrual cycle but does not stimulate ovulation.
**Option B:** Progestin-only therapy causes endometrial shedding but lacks follicular stimulation.
**Option C:** GnRH agonist requires a functional pituitary to release LH/FSH, which is absent here.
**Option D:** Oral contraceptives suppress the HPG axis, worsening amenorrhea.

**Clinical Pearl / High-Yield Fact**
In pituitary dysfunction, exogenous gonadotropins (FSH + LH) are required for ovulation. Estrogen/progestin regimens only mimic cycles

✓ Correct Answer: D. Human menopausal or recombinant gonadotropin, followed by hCG